Iksuda Therapeutics
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Helix Draymans Newcastle Way, Newcastle ...Phone Number
+44 1916031680Website
www.iksuda.comRevenue
<$5 MillionIndustry
About Iksuda Therapeutics
Iksuda Therapeutics is a biotechnology company specializing in the development of antibody-drug conjugates (ADCs) aimed at treating hard-to-treat cancers. Their innovative approach focuses on creating class-leading ADCs with enhanced tumor specificity through tailored design and advanced payload mechanisms. The company collaborates with research institutions and industry partners to leverage its expertise and proprietary technologies in ADC development. Iksuda's clinical pipeline underscores its commitment to optimizing anti-cancer efficacy while ensuring patient safety.Explore more
Iksuda Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Iksuda Therapeutics
Compare insights from companies similar to Iksuda Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Iksuda Therapeutics Tech Stack
A closer look at the technologies used by Iksuda Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Iksuda Therapeutics
Sign Up For FreeTo access detailed company insights
Iksuda Therapeutics is a biotechnology company specializing in the development of antibody-drug conjugates (ADCs) aimed at treating hard-to-treat cancers. Their innovative approach focuses on creating class-leading ADCs with enhanced tumor specificity through tailored design and advanced payload mechanisms. The company collaborates with research in... Read More
